זולדרוניק טבע 4 מ"ג/5 מ"ל

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

ZOLEDRONIC ACID AS MONOHYDRATE 4 MG/VIAL

Commercializzato da:

ABIC MARKETING LTD

Codice ATC:

M05BA08

Forma farmaceutica:

CONCENTRATE FOR SOLUTION FOR INFUSION

Via di somministrazione:

I.V

Prodotto da:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Gruppo terapeutico:

ZOLEDRONIC ACID

Indicazioni terapeutiche:

Treatment of hypercalcaemia of malignancy. Treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.

Data dell'autorizzazione:

2013-11-01